Print Page

被 发 现 含 有 未 标 示 西 药 的 产 品

 
The United States: Public Notification: Body Shape Weight Loss System contains hidden drug ingredient sibutramine (English only)
 
The US Food and Drug Administration (FDA) is advising consumers not to purchase or use Body Shape Weight Loss System, a product promoted for weight loss. This product was identified during an examination of imported goods. FDA laboratory analysis confirmed that Body Shape Weight Loss System contains sibutramine. Sibutramine is a controlled substance that was removed from the market in Oct 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.

Please refer to the following website in FDA for details: http://www.fda.gov/drugs/medication-health-fraud/public-notification-body-shape-weight-loss-system-contains-hidden-drug-ingredient-0

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Wednesday, Nov 25, 2020
Issued at HKT 14:00
 
Related Information:
The United States: Public Notification: Body Shape Weight Loss System contains h... 上载于 2024-10-03
美国:公告:Body Shape Weight Loss System含有未标示药物成分酚酞 上载于 2018-07-04
 
back